Humane Genomics

Emerging

Company Overview

Humane Genomics is a biotechnology company that engineers synthetic oncolytic viruses to selectively target and destroy cancer cells using its proprietary synthetic virology platform. The company has raised $8.12M in total funding, including a February 2025 round led by Union Square Ventures, with backing from 14 investors. Humane Genomics serves cancer patients and oncology centers globally with RNA-based viral therapies designed for systemic delivery and extended therapeutic duration.

Revenue
$8.12M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Humane Genomics is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Humane Genomics performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Humane Genomics

See exactly how Humane Genomics ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Humane Genomics stacks up against competitors with our detailed comparison tool.

Start Comparison